Table 2.
Bacterial infections according to the antibiogram/fungogram (sensitive, intermediate sensitive, resistant).
| Infection | No. Study/Control Group |
The Antibiotic Sensitivity Profiles | p-Value | ||
|---|---|---|---|---|---|
| Sensitive | Intermediately Sensitive | Resistant | |||
| P. aeruginosa | 24/10 | AK, CAZ, CEF, CIP, IPM, GM, LVX, MERO, PIP, TZP | S, CEF, IPM, LVX | CRO, CZ, CIP, LVX, MERO, PIP, TIC, TM | 0.020 |
| Proteus mirabilis | 2/1 | AK, AM, AMC, CEF, CZ, GM, IPM, SXT | IPM | - | 0.042 |
| Enterococcus sp. | ½ | AM, AMC, CM, E, GM, VA | CIP | - | 0.054 |
| Staphylococcus aureus | 3/3 | GM, CIP, CM, SXT | - | CXM, CM, OX | 0.049 |
| Acinetobacter baumannii | 1/1 | AK, CFP, IPM, MERO | - | CAZ, CEF, CIP | 0.219 |
| Klebsiella spp. | 2/1 | AK, AM, MERO, IPM, GM, PIP, TZP | GM | SXT | 0.015 |
| Escherichia coli | 1/3 | AK, AM, CRO, CEF, CIP, IPM, GM, PIP, TZP | - | LVX, SXT | 0.243 |
| Providencia rettgeri | 1/0 | AK, CAZ, CEF, CIP, IPM, GM | - | - | 1.015 |
| Group B Streptococcus | 1/0 | AM, AMC, CXM, GM, LVX | - | CM, E, SXT | 0.354 |
| Candida albicans | 1/0 | ECN, MIC, AMB, FCZ, NYS; VOR | - | 5-FC | 2.540 |
| Salmonella Paratyphi B | 1/0 | AM, AMC, CRO, GM, LVX | - | CM, E | 1.024 |
| Morganella morganii | 0/1 | AK, CRO, CZ, CEF, CIP, IPM, GM, MERO, LVX, PIP | AMC | SXT | 0.810 |
Amikacin = AK; Ceftazidime = CAZ; Ceftriaxone = CRO; Cefazolin = CZ; Cefepime = CEF; Cefuroxime = CXM; Cefoperazone = CFP; Ciprofloxacin = CIP; Imipenem = IPM; Gentamicin = GM; Levofloxacin = LVX; Meropenem = MERO; Piperacillin = PIP; Piperacillin+tazobactam = TZP; Streptomycin = S; Ticarcillin = TIC; Tobramycin = TM; Ampicillin = AM; Oxacillin = OX; Amoxicillin + clavulanic acid = AMC; Trimethoprim/sulfamethoxazole = SXT; Clindamycin = CM; Erythromycin = E; Vancomycin = VA; Econazole = ECN; Miconazole = MIC; Amphotericin B = AMB; Fluconazole = FCZ; Nystatin = NYS; Voriconazole = VOR; 5-Fluorocytosine = 5-FC.